Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT01503541
What this trial is testing

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin

Who this might be right for
Leukemia
SWOG Cancer Research Network 365
Early research (Phase 1)Study completedNCT03813186
What this trial is testing

Effect of Food on Blood Levels of ASTX727

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Astex Pharmaceuticals, Inc. 18
Not applicableLooking for participantsNCT06513273
What this trial is testing

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

Who this might be right for
Acute Myeloid LeukemiaAML, AdultAcute Myeloid Leukemia, Adult
Gruppo Italiano Malattie EMatologiche dell'Adulto 397
Testing effectiveness (Phase 2)Looking for participantsNCT07228273
What this trial is testing

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
OHSU Knight Cancer Institute 102
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00002792
What this trial is testing

Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07238712
What this trial is testing

Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

Who this might be right for
Acute Myeloid Leukemia (AML)Chronic Myeloid LeukemiaMyelodysplastic Syndromes (MDS)+2 more
St. Petersburg State Pavlov Medical University 60
Not applicableLooking for participantsNCT03125707
What this trial is testing

German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)

Who this might be right for
BCR-ABL1-Negative Myeloid Neoplasms
University of Ulm 2,172
Testing effectiveness (Phase 2)Study completedNCT02768792
What this trial is testing

High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia, in Relapse
UNC Lineberger Comprehensive Cancer Center 38
Not applicableStudy completedNCT04589728
What this trial is testing

Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 202
Not applicableStudy completedNCT00005892
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Who this might be right for
Fanconi's AnemiaMyelodysplastic SyndromesLeukemia, Nonlymphocytic, Acute+1 more
Fairview University Medical Center
Early research (Phase 1)Ended earlyNCT04755244
What this trial is testing

Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)

Who this might be right for
Acute Myeloid LeukemiaAML, Adult
ALX Oncology Inc. 14
Not applicableStudy completedNCT01144793
What this trial is testing

Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias

Who this might be right for
Leukemia, LymphocyticLeukemia, Myeloid
Stanford University 17
Large-scale testing (Phase 3)Looking for participantsNCT03013998
What this trial is testing

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Who this might be right for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Beat AML, LLC 3,000
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Not applicableLooking for participantsNCT04777916
What this trial is testing

Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Acute Leukemia French Association 5,000
Not applicableLooking for participantsNCT06874257
What this trial is testing

Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade

Who this might be right for
AML (Acute Myelogenous Leukemia)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Testing effectiveness (Phase 2)Ended earlyNCT00245128
What this trial is testing

Imatinib Mesylate in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myeloproliferative Disorders
OHSU Knight Cancer Institute 10
Not applicableStudy completedNCT00339664
What this trial is testing

Analyses of Human Samples Collected in Clinical Trials

Who this might be right for
Leukemia, MyeloidNeoplasm MetastasisLeukemia, Lymphoid+1 more
National Cancer Institute (NCI) 2,579
Next Page